Dear AuntMinnie Member,
Imaging professionals in the U.S. have a new tool in their battle against breast cancer with today's news that Fujifilm Medical Systems USA received final approval for its computed radiography-based digital mammography system.
The U.S. Food and Drug Administration signed off on Fuji's premarket approval (PMA) application for its FCRm system after giving the Stamford, CT, vendor an approvable letter in May. Fuji is now able to market FCRm in the U.S. after years of selling CR mammography in international markets.
As explained in a Technology Review article in our Women's Imaging Digital Community, CR mammography could reshape the breast imaging landscape by giving facilities a less expensive option for going digital. Current flat-panel digital technology requires centers to buy a completely new system that could be several times the price of an analog mammography unit, while CR mammography enables facilities to use much of their existing equipment.
Get the details of the approval and find out if CR mammography could be right for your facility by clicking here.
In other women's imaging news, we're featuring a story on a paper out today in the Journal of the American Medical Association that concludes that female smokers may have higher rates of lung cancer than men. And paradoxically, women are also more likely to survive the disease than men, according to the latest results from the Early Lung Cancer Action Project (ELCAP) study. Get that story by clicking here.
Finally, find out why women's imaging vendor Hologic has agreed to sell the stereotactic breast biopsy table technology it recently acquired from Fischer Imaging to the parent company of Siemens Medical Solutions in an article available by clicking here.
Get these stories and more in the Women's Imaging Digital Community at women.auntminnie.com.
